Sanofi-Aventis, a pharmaceutical firm in Egypt and the largest in Europe, has launched an anti-counterfeit medication initiative in cooperation with the Egyptian health ministry. The three-phase initiative aims to protect patients through fighting counterfeit medication in the Egyptian market.
You might also like...
Policy designates Masdar, Adnoc as hydrogen coinvestors
29 March 2024
Waste energy projects find relevance
29 March 2024
Iraq signs five-year gas deal with Iran
29 March 2024
Iraq pushing forward with refinery project
29 March 2024
A MEED Subscription...
Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.